Tamarind Hill specializes in early-stage venture capital for B2B healthcare innovators, leveraging extensive networks and industry experience to support founders.
Key people at Tamarind Hill.
Tamarind Hill is an early-stage venture capital firm specializing in investing in high-growth technology businesses within the B2B healthcare sector, particularly Healthcare IT and supply chain infrastructure. Their mission is to partner with digital healthcare entrepreneurs to develop scalable solutions that decentralize care, improve the economics of care, and enhance supply chain efficiency on a global scale. Tamarind Hill supports companies that have achieved early product-market fit, helping them transition to scalable commercialization through strategic guidance and growth capital. Their impact on the startup ecosystem is significant in fostering innovation that improves healthcare delivery and operational efficiency[1][2][3][4].
Founded in 2017 and based in Ohio, Tamarind Hill was established by a team of industry veterans with deep expertise in healthcare and technology sectors. Key partners include Managing Partners Mark Shary and Ben Trumbull, along with Operating Partner Josh Buehler. The firm evolved with a focused thesis on early-stage investments in healthcare IT and supply chain technology, aiming to unlock potential in MidAmerica and beyond. Their approach is operator-first, leveraging their own successful entrepreneurial and investment experiences to guide portfolio companies from product-market fit to growth and exits[6][7].
Tamarind Hill rides the growing trend of digital transformation in healthcare, particularly the shift toward decentralized care models and the optimization of healthcare supply chains. The timing is critical as healthcare systems worldwide seek cost reduction, improved patient access, and operational efficiencies. Market forces such as rising healthcare costs, regulatory pressures, and technological advancements in AI and SaaS platforms favor Tamarind Hill’s investment thesis. By backing companies that address these systemic challenges, Tamarind Hill influences the broader ecosystem by accelerating innovation adoption and improving healthcare delivery on a scalable basis[1][4].
Looking ahead, Tamarind Hill is poised to deepen its influence by continuing to back pioneering healthcare IT and supply chain startups that leverage AI, automation, and data-driven solutions. Trends such as telemedicine expansion, AI-driven care models, and supply chain digitization will shape their portfolio’s growth trajectory. Their operator-first approach and sector specialization position them well to capitalize on emerging opportunities and drive meaningful impact in healthcare innovation. Tamarind Hill’s future will likely involve scaling their portfolio companies toward larger exits and expanding their footprint in the evolving healthcare technology landscape[4][7].
Key people at Tamarind Hill.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Dec 1, 2023 | Thrivable | $6.0M Seed | — | Sixty8 Capital |
| Jul 1, 2022 | Nymbl Systems | $2.0M Seed | — | Rev1 Ventures |
| Jul 1, 2019 | GoWild | $2.0M Seed | — | Keyhorse Capital |
